| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Payment of taxes on restricted share units withheld for taxes | 618 | 156 |
| Net cash provided by financing activities | 57,529 | 1,326 |
| Net change in cash and cash equivalents | -66,598 | -22,486 |
| Cash and cash equivalents at beginning of period | 169,510 | - |
| Cash and cash equivalents at end of period | 102,912 | - |
Structure Therapeutics Inc. (GPCR)
Structure Therapeutics Inc. (GPCR)